Is the CPT code for the administration of the Novavax Adjuvanted booster recognized by Medicare?
Yes. CMS announced the administration code for the Novavax Adjuvanted booster dose for patients 18 years and older (CPT 0044A) will be effective October 19, 2022. Its long descriptor is listed as:
- 0044A -- Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; booster dose
The Novavax vaccine product code (CPT 91304) remains unchanged. Its long descriptor is provided below for your convenience:
- 91304 -- Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use
For additional information, see:
MLN Matters, 11/03/2022